Pathogenic variants in AIMP1 gene are rare causes of neurologic disorders. Homozygous frameshift and nonsense variants in AIMP1 have been described in severe neurodegenerative disease. This is the third report of a homozygous nonsense variant in AIMP1 [c.115 C > T (p.Gln39*)] in a girl with severe neonatal onset epileptic encephalopathy. Like the two other cases reported, our patient is also of Filipino descent. Clinical features include microcephaly, poor visual motor development, shallow breathing, severe hypertonia in extremities, severe global developmental delay, poor gag and suck reflex, failure to thrive in the neonatal period, and early onset intractable seizures. Brain MRI showed hypoplasia of corpus callosum as well as cerebellar vermis, global volume loss and diminished myelination for her age. Electroencephalogram at four months of age showed background consisting of synchronous and asynchronous intervals of burst suppression with intermittent multifocal spikes predominantly in the bi-temporal region, suggestive of Early Onset Epileptic Encephalopathy with Burst Suppression (EOEE-BS) which has not been previously associated with the c.115 C > T variant in AIMP1. Of note, she presented to us in super refractory status epilepticus which was eventually controlled after administration of ketogenic diet and Epidiolex (cannabidiol). This report expands the genetic landscape of EOEE-BS. This is the first case of this specific variant in which Epidiolex was administered, which along with Ketogenic diet aided in controlling patient’s super refractory status epilepticus.
Keywords: AIMP1; EOEE-BS; Epileptic encephalopathy; Neurodegenerative diseases.
Copyright © 2020. Published by Elsevier Masson SAS.
Genetic diagnosis and clinical characteristics by etiological classification in early-onset epileptic encephalopathy with burst suppression pattern.
Epilepsy Res. 2020 Jul;163:106323. doi: 10.1016/j.eplepsyres.2020.106323. Epub 2020 Mar 27. Epilepsy Res. 2020. PMID: 32247221
[Genotype and phenotype of children with KCNA2 gene related developmental and epileptic encephalopathy].
Zhonghua Er Ke Za Zhi. 2020 Jan 2;58(1):35-40. doi: 10.3760/cma.j.issn.0578-1310.2020.01.009. Zhonghua Er Ke Za Zhi. 2020. PMID: 31905474 Chinese.
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy.
Epilepsia Open. 2019 Aug 11;4(3):464-475. doi: 10.1002/epi4.12353. eCollection 2019 Sep. Epilepsia Open. 2019. PMID: 31440727 Free PMC article.
2010 Apr 27 [updated 2018 Sep 27]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. GeneReviews®. 1993–2020. PMID: 20437616 Free Books & Documents. Review.
2013 Nov 26 [updated 2020 May 21]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. GeneReviews®. 1993–2020. PMID: 24278995 Free Books & Documents. Review.